Anne Beaubrun

771 total citations
28 papers, 508 citations indexed

About

Anne Beaubrun is a scholar working on Hematology, Infectious Diseases and Genetics. According to data from OpenAlex, Anne Beaubrun has authored 28 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Infectious Diseases and 8 papers in Genetics. Recurrent topics in Anne Beaubrun's work include Iron Metabolism and Disorders (8 papers), Hemoglobinopathies and Related Disorders (8 papers) and HIV/AIDS Research and Interventions (6 papers). Anne Beaubrun is often cited by papers focused on Iron Metabolism and Disorders (8 papers), Hemoglobinopathies and Related Disorders (8 papers) and HIV/AIDS Research and Interventions (6 papers). Anne Beaubrun collaborates with scholars based in United States, United Kingdom and Germany. Anne Beaubrun's co-authors include Frederick L. Altice, Obaro Evuarherhe, M. Alan Brookhart, Brian D. Bradbury, Janet K. Freburger, Ryan D. Kilpatrick, Joshua Cohen, Yi Qian, Peter P. Tóth and Guillermo Villa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Anne Beaubrun

27 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Beaubrun United States 11 221 104 98 94 77 28 508
Lauren E. Cain United States 11 109 0.5× 63 0.6× 15 0.2× 59 0.6× 27 0.4× 19 688
Karthik Ranganna United States 13 86 0.4× 109 1.0× 89 0.9× 161 1.7× 20 0.3× 28 476
Robert Dressler United States 12 102 0.5× 90 0.9× 132 1.3× 98 1.0× 75 1.0× 20 465
Howard Baron United States 10 39 0.2× 187 1.8× 14 0.1× 196 2.1× 52 0.7× 15 606
B. Baird United States 9 115 0.5× 162 1.6× 158 1.6× 99 1.1× 7 0.1× 13 560
Nicola Wearne South Africa 13 184 0.8× 66 0.6× 338 3.4× 37 0.4× 118 1.5× 51 598
Mazou Ngou Temgoua Cameroon 12 53 0.2× 57 0.5× 11 0.1× 48 0.5× 23 0.3× 46 431
Mickaël Basson France 5 28 0.1× 196 1.9× 11 0.1× 101 1.1× 15 0.2× 6 527
Yazan Al Salhi Italy 15 183 0.8× 92 0.9× 28 0.3× 156 1.7× 180 2.3× 62 763
Tiruneh Adane Ethiopia 12 80 0.4× 96 0.9× 8 0.1× 21 0.2× 16 0.2× 42 343

Countries citing papers authored by Anne Beaubrun

Since Specialization
Citations

This map shows the geographic impact of Anne Beaubrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Beaubrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Beaubrun more than expected).

Fields of papers citing papers by Anne Beaubrun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Beaubrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Beaubrun. The network helps show where Anne Beaubrun may publish in the future.

Co-authorship network of co-authors of Anne Beaubrun

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Beaubrun. A scholar is included among the top collaborators of Anne Beaubrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Beaubrun. Anne Beaubrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montalembert, Mariane de, Fernando Ferreira Costa, Baba Inusa, et al.. (2024). Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease. European Journal Of Haematology. 113(2). 172–182. 2 indexed citations
2.
Beaubrun, Anne, et al.. (2024). A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses. Journal of Medical Economics. 27(1). 430–441. 4 indexed citations
5.
Brown, R. Clark, Modupe Idowu, Richard A. Drachtman, et al.. (2023). Patient‐Reported Experiences in Voxelotor‐Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study. BioMed Research International. 2023(1). 7533111–7533111. 6 indexed citations
6.
9.
Lovelace, Belinda, Anne Beaubrun, Mark J. Alberts, et al.. (2020). Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission Database. SHILAP Revista de lepidopterología. 4(3). e211–e217. 6 indexed citations
10.
Elion, Richard, Mina Kabiri, Kenneth H. Mayer, et al.. (2019). Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States. International Journal of Environmental Research and Public Health. 16(9). 1592–1592. 16 indexed citations
11.
Altice, Frederick L., et al.. (2019). <p>Adherence to HIV treatment regimens: systematic literature review and meta-analysis</p>. Patient Preference and Adherence. Volume 13. 475–490. 140 indexed citations
12.
Ding, Yao, et al.. (2019). <p>Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment</p>. Patient Preference and Adherence. Volume 13. 1927–1939. 19 indexed citations
13.
Sutton, S. Scott, et al.. (2018). Chronic kidney disease, cardiovascular disease, and osteoporotic fractures in patients with and without HIV in the US Veteran’s Affairs Administration System. Current Medical Research and Opinion. 35(1). 117–125. 14 indexed citations
14.
Monda, Keri L., Suying Li, Anne Beaubrun, et al.. (2016). Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates. American Journal of Kidney Diseases. 68(2). 266–276. 4 indexed citations
15.
Chertow, Glenn M., Jiannong Liu, Keri L. Monda, et al.. (2016). Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. Journal of the American Society of Nephrology. 27(10). 3129–3138. 33 indexed citations
16.
Beaubrun, Anne, et al.. (2013). Temporal Trends in Fracture Rates and Postdischarge Outcomes among Hemodialysis Patients. Journal of the American Society of Nephrology. 24(9). 1461–1469. 85 indexed citations
17.
Beaubrun, Anne. (2012). Extending Medicare Immunosuppressive Medication Coverage. Journal of Health Care for the Poor and Underserved. 23(1). 20–27. 1 indexed citations
18.
Beaubrun, Anne, M. Alan Brookhart, Betsy Sleath, Lily Wang, & Abhijit V. Kshirsagar. (2012). Trends and Variations in Intravenous Vitamin D Use among Hemodialysis Patients in the United States. Renal Failure. 35(1). 1–8. 9 indexed citations
19.
Beaubrun, Anne, Eiichiro Kanda, T. Christopher Bond, & William M. McClellan. (2012). Form CMS-2728 Data Versus Erythropoietin Claims Data: Implications for Quality of Care Studies. Renal Failure. 35(3). 320–326. 5 indexed citations
20.
Beaubrun, Anne, et al.. (2011). PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES. Value in Health. 14(3). A129–A129. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026